Vermont Center for Reproductive Medicine, Burlington, VT – FDA Inspections

Inspection records and compliance data for Vermont Center for Reproductive Medicine in Burlington, Vermont. 6 FDA inspections on record, last inspected December 14, 2023.

Company Profile

This profile covers Vermont Center for Reproductive Medicine based in Burlington, Vermont, United States.

FDA Inspection History

FDA inspections: 6
OAI: 0
VAI: 0
NAI: 6
Form 483s: 0
Warning letters: 0

First inspected July 30, 2009. Last inspected December 14, 2023.

FDA inspections (6)

Date	Result	FDA center(s)	Insp. #
December 14, 2023	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	1226658
October 31, 2017	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	1034326
October 2, 2015	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	945654
November 6, 2012	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	808334
February 23, 2011	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	715662
July 30, 2009	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	602185

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Kristen Pierce, MD

Fletcher Allen Health Care Acute Dialysis/Apheresis Unit

Veterans Admin. Medical & Regional Office Ctr Blood Bank

American Red Cross Biomedical Services Northern New England Region

Edward F. Kent, Jr., MD

Brattleboro Memorial Hospital/bb

IVF Laboratories of Vermont, LLC

University of Vermont Medical Center

Upstate New York Transplant Services Inc

Martin Worth Medical SW LLC